Application of antibody‐mediated extraction for the stereoselective determination of the active metabolite of loxoprofen in human and rat plasma
- 1 January 1992
- Vol. 4 (5) , 308-315
- https://doi.org/10.1002/chir.530040509
Abstract
Antibody-mediated extraction followed by chiral high-performance liquid chromatography (HPLC) was applied to stereoselective determination in human and rat plasma of the active metabolite [(2S,1]R,2[S)-trans-alcohol] with three chiral centers of Loxoprofen, a 2-arylpropionic acid antiinflammatory agent after oral administration. Antiserum against the (1'R,2'S)-cyclopentanol moiety was obtained from a rabbit immunized with bovine serum albumin conjugate linked to the propionic acid moiety, in which another chiral center is located. Then, the immunoglobulin G purified by a protein A column was coupled to BrCN-activated Sepharose 4B. Plasma samples were applied to the immobilized antibody column. After washing the column to remove unrequired stereoisomers, a mixture of two diastereomers whose configurations were 1'R,2'S in the cyclopentanol moiety was extracted with 95% methanol. The solvent was evaporated and the residue was derivatized with (+)-(R)-1-(1-naphthyl)ethylamine as a chiral reagent to separate the diastereomers by HPLC. This combined analytical method showed the stereoselective metabolism of Loxoprofen in human, that is, 64% of the total amount of four trans-alcohol stereoisomers was in the 2S, 1'R,2'S form, which is the active metabolite. This phenomenon was also observed in rats given Loxoprofen and its (2S)- and (2R)-isomers, and is explained by stereoselective ketone reduction of Loxoprofen to the (1'R,2'S)-trans-alcohol and inversion from 2R to 2S in the propionic acid moiety. Antibody-mediated extraction should be a selective and simple clean-up method for determining haptens with complicated structures, combined with an appropriate analytical method.Keywords
This publication has 19 references indexed in Scilit:
- Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug developmentChirality, 1991
- Regulatory aspects of the development of chiral drugs in Japan: A status reportChirality, 1991
- High-performance liquid chromatographic determination of loxoprofen and its diastereomeric alcohol metabolites in biological fluids by fluorescence labelling with 4-bromomethyl-6,7-methylenedioxycoumarinJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Use of monoclonal antibodies to separate the enantiomers of abscisic acidAnalytical Biochemistry, 1986
- A comparison of chromogenic substrates for horseradish peroxidase as a label in steroid enzyme immunoassay.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Column liquid chromatography for the simultaneous determination of the enantiomers of loxoprofen sodium and its metabolites in human urineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivoBiochemical Pharmacology, 1984
- Purification and some properties of ketone reductase forming an active metabolite of sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate dihydrate(loxoprofen sodium), a new anti-inflammatory agent, in rabbit liver cytosol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Synthesis of the eight possible optically active isomers of 2-(4-(2-hydroxycyclopentylmethyl)phenyl)propionic acid.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Selective enzyme purification by affinity chromatography.Proceedings of the National Academy of Sciences, 1968